Business Daily Media

Biogen and Eisai launch initiatives to help patients with Alzheimer's disease access ADUHELM

  • Written by ACN Newswire - Press Releases

Biogen and Eisai launch initiatives to help patients with Alzheimer's disease access ADUHELM

Cambridge, MA, Jun 8, 2021 - (JCN Newswire) - Following U.S. Food and Drug Administration's (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as the first and only Alzheimer's disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain, Biogen (Nasdaq: BIIB) and Eisai Inc., U.S.

Read more //?#

Should You Build or Buy Your New Home?

To build or buy your first home, that is the question. Spoiler alert: building is better. Why? We’re about to tell you seven reasons why building ...

Property

13 Top Advantages of Owning a Real Estate Photography Business

Starting a real estate photography business can be both rewarding and practical, especially for those who have a passion for photography and an in...

Business Training

10 Terms to Include In Your Lease Or Rental Agreement

A rental or lease agreement outlays the rules agreed upon by landlords and tenants for their rental relationship. This agreement is a legally bind...

Business Training

Judging Pay Properly: Top Software for Construction Estimates

Did you know that there are 1.55 new housing units planned each year in the United States? That is a ton of building projects that require constru...

Business Training

Proptech Soho.com.au adds Sotheby’s International Realty properties to its platform

AI-powered personalised real estate platform Soho.com.au, has announced today it is collaborating with Sotheby’s International Realty to showcase ...

Property

7 Tips To Make The Most Out Of Your Coworking Space

The importance of a vibrant, flexible, and inspiring workspace cannot be overstated in a world where the boundaries of work and personal life cont...

Business Training